· Periodic Report
Q3 operating loss of KRW 4.4 billion, turning to a loss; revenue KRW 51.3 billion
Sinpoong Pharm sold KRW 51.3 billion in the third quarter and lost KRW 4.4 billion from its main business, turning from profit to loss versus a year earlier.